Cytek Biosciences Q4 EPS $0.07 Beats $0.05 Estimate, Sales $57.48M Miss $59.38M Estimate

Author: Benzinga Newsdesk | February 27, 2025 05:23pm
Cytek Biosciences (NASDAQ:CTKB) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 75 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $57.48 million which missed the analyst consensus estimate of $59.38 million by 3.21 percent. This is a 1.30 percent decrease over sales of $58.23 million the same period last year.

Posted In: CTKB